To address the high costs of health care services, prescription drugs, and health insurance coverage in the United States, and for other purposes.
This bill was introduced in the House on May 13, 2026, and sent to several committees for review. It is currently stalled because it has not received any action from these committees since that date. The bill must be reviewed by these committees before it can move forward in the legislative process.
Govbase has not yet run an impact analysis on this legislation.
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Education and Workforce, the Judiciary, Oversight and Government Reform, Rules, the Budget, Armed Services, and House Administration, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.
Introduced in House
The bill was officially filed and given a number. It now enters the legislative queue.
No votes, news coverage, or related bills recorded for this bill yet.
Document Type
Congressional Bill
Analysis generated by AI. Always verify with official sources.